October 1995
Volume 36, Issue 11
Free
Articles  |   October 1995
Adenovirus-mediated heme oxygenase-1 gene transfer into rabbit ocular tissues.
Author Affiliations
  • N G Abraham
    Laboratory of Clinical Pharmacology, Rockefeller University, New York, NY 10021, USA.
  • J L da Silva
    Laboratory of Clinical Pharmacology, Rockefeller University, New York, NY 10021, USA.
  • Y Lavrovsky
    Laboratory of Clinical Pharmacology, Rockefeller University, New York, NY 10021, USA.
  • R A Stoltz
    Laboratory of Clinical Pharmacology, Rockefeller University, New York, NY 10021, USA.
  • A Kappas
    Laboratory of Clinical Pharmacology, Rockefeller University, New York, NY 10021, USA.
  • M W Dunn
    Laboratory of Clinical Pharmacology, Rockefeller University, New York, NY 10021, USA.
  • M L Schwartzman
    Laboratory of Clinical Pharmacology, Rockefeller University, New York, NY 10021, USA.
Investigative Ophthalmology & Visual Science October 1995, Vol.36, 2202-2210. doi:
  • Views
  • PDF
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      N G Abraham, J L da Silva, Y Lavrovsky, R A Stoltz, A Kappas, M W Dunn, M L Schwartzman; Adenovirus-mediated heme oxygenase-1 gene transfer into rabbit ocular tissues.. Invest. Ophthalmol. Vis. Sci. 1995;36(11):2202-2210.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
This content is PDF only. Please click on the PDF icon to access.
Abstract

PURPOSE: Heme oxygenase-1 (HO-1) is a stress protein induced up to 100-fold within a few hours after exposure to oxidative stress, and it has been shown to counteract oxidative injury induced by ultraviolet light or free radicals. The current study was undertaken to determine whether the HO-1 gene can be introduced into adult rabbit ocular tissues by microinjection of a recombinant replication-deficient adenovirus human HO-1 cDNA (Adv-HHO). METHODS: Human HO-1 gene was used for transfection studies to differentiate endogenous from transfected HO. The purified Adv-HHO construct (10(8) pfu/ml) was mixed with lipofectamine and microinjected into the anterior chamber, vitreous cavity, and subretinal space of New Zealand rabbit eyes. After 2 weeks, total RNA was extracted from different ocular tissues, reverse transcription-polymerase chain reaction was performed using specific human HO-1 primers, and amplification products were subjected to Southern hybridization. RESULTS: Transfection with the Adv-HHO construct into rabbit corneal epithelial cells in culture resulted in a functional expression of the human HO-1 gene; the human HO-1 mRNA was detected, and enzyme activity increased threefold. Human HO-1 mRNA was detected in the retina after microinjection of the Adv-HHO construct into the subretinal space. Microinjection into the vitreous resulted in HO-1 mRNA expression in the corneal endothelium, iris, lens, and retina; after intracameral injection of the Adv-HHO construct, human HO-1 mRNA was detected in corneal epithelium and endothelium, ciliary body, lens, and iris. Regardless of the injection site, transfected human HO-1 mRNA was undetectable in tissues outside the eye, that is, brain, liver, and kidney. CONCLUSIONS: These results demonstrated a tissue-selective functional transfer of the human HO-1 gene into rabbit ocular tissues in vivo. This technique may be a promising means for delivering HO-1 gene in vivo as a protective mechanism against oxidative stress that contributes to the pathogenesis of ocular diseases such as cataract, light-induced injury, age-related macular degeneration, and diabetic retinopathy.

×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×